Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,189 INR
Change Today +31.10 / 2.69%
Volume 910.0K
STR On Other Exchanges
Symbol
Exchange
Natl India
As of 6:02 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

strides arcolab ltd (STR) Snapshot

Open
1,179
Previous Close
1,157
Day High
1,222
Day Low
1,149
52 Week High
08/20/15 - 1,374
52 Week Low
09/26/14 - 542.65
Market Cap
70.9B
Average Volume 10 Days
776.1K
EPS TTM
0.26
Shares Outstanding
59.6M
EX-Date
07/22/15
P/E TM
4,571.3x
Dividend
3.00
Dividend Yield
9.09%
Current Stock Chart for STRIDES ARCOLAB LTD (STR)

Related News

No related news articles were found.

strides arcolab ltd (STR) Related Businessweek News

View More BusinessWeek News

strides arcolab ltd (STR) Details

Strides Arcolab Limited, a pharmaceutical company, develops, manufactures, and sells pharmaceutical products in Africa, Australasia, North America, Europe, South and Central America, India, and internationally. The company operates through Pharmaceutical and Biotech segments. It develops generic pharmaceutical product portfolio in therapeutic segments, such as immune-suppressants, anti-viral, and antibiotics; and offers general tablets, hard and soft gelatin capsules, sachets, potent drugs, semi-solids, ointments and creams, and liquids and syrups in the areas of therapeutic segments for prescription, OTC, and nutraceutical markets. Strides Arcolab Limited also provides branded generic products, as well as non-prescription pharmacy products; supplies drugs in the anti-retroviral and anti-malaria segments; and is involved in bio generics business. The company was formerly known as Strides Pharmaceuticals Private Limited and changed its name to Strides Arcolab Limited in 1996. Strides Arcolab Limited was founded in 1990 and is headquartered in Bengaluru, India.

1,925 Employees
Last Reported Date: 05/30/15
Founded in 1990

strides arcolab ltd (STR) Top Compensated Officers

Founder, Executive Vice Chairman, Group Chief...
Total Annual Compensation: 53.7M
Chief Financial Officer, Compliance Officer a...
Total Annual Compensation: 22.9M
Compensation as of Fiscal Year 2015.

strides arcolab ltd (STR) Key Developments

Strides Arcolab Ltd. Receives ANDA Approval from US FDA for Benzonatate Softgel Capsules

Strides Arcolab Ltd. announced that it has received approval from the United States Food & Drug Administration (USFDA) for benzonatate capsules USP, 100 mg and 200 mg. The product will be manufactured at the company’s oral dosage facility in Bengaluru and marketed by Strides in the US Market. The product will be launched immediately.

Strides Arcolab Ltd. Announces Consolidated and standalone Unaudited Earnings Results for First Quarter Ended June 30, 2015

Strides Arcolab Ltd. announced consolidated and standalone unaudited earnings results for first quarter ended June 30, 2015. For the quarter, the company reported total income from operations of INR 2,697.865 million, profit from operations before other income, finance costs and exceptional items of INR 187.878 million, profit from ordinary activities before tax of INR 649.311 million, net profit of INR 418.593 million or INR 7 diluted per share, compared to the total income from operations of INR 2,542.964 million, profit from operations before other income, finance costs and exceptional items of INR 291.249 million, profit from ordinary activities before tax of INR 271.476 million, net profit of INR 189.857 million or INR 2.8 diluted per share, for the same quarter a year ago. For the quarter, the company reported standalone total income from operations of INR 2,193.121 million, profit from operations before other income, finance costs and exceptional items of INR 112.358 million, profit from ordinary activities before tax of INR 678.206 million, net profit of INR 480.26 million or INR 8.03 diluted per share, compared to the total income from operations of INR 2,008.007 million, profit from operations before other income, finance costs and exceptional items of INR 215.447 million, profit from ordinary activities before tax of INR 378.552 million, net profit of INR 267.957 million or INR 4.49 diluted per share, for the same quarter a year ago.

Strides Arcolab Ltd., Q1 2016 Earnings Call, Jul 30, 2015

Strides Arcolab Ltd., Q1 2016 Earnings Call, Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STR:IN 1,188.55 INR +31.10

STR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,083 GBp -1.00
Endo International PLC $79.00 USD +2.62
Johnson & Johnson $96.22 USD +1.11
Merck & Co Inc $54.95 USD +0.53
Pfizer Inc $33.26 USD +0.83
View Industry Companies
 

Industry Analysis

STR

Industry Average

Valuation STR Industry Range
Price/Earnings 100.0x
Price/Sales 5.3x
Price/Book 5.6x
Price/Cash Flow 6.9x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STRIDES ARCOLAB LTD, please visit www.stridesarco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.